Anti-Human/Mouse/Rat NFκB-p65 Antibody
Anti-Human/Mouse/Rat NFκB-p65 Antibody with collaborator-tested evidence for WB, IHC-P. Read more ›
["WBProduct Description
NFκB-p65 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human, Mouse, Rat; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, IHC-p. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Synthesized peptide derived from human NFκB-p65 around the non-phosphorylation site of Ser281.; purification: Affinity purification; concentration: 1 mg/mL.
Database references: UniProt: Q04206 | NCBI Gene: 5970.
Research Use Only.
Key Facts
| Target | NFκB-p65 |
| Also known as | Avian reticuloendotheliosis viral (v rel) oncogene homolog A, MGC131774, NF kappa B p65delta3, NFKB3, Nuclear Factor NF Kappa B p65 Subunit, Nuclear fact, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B cells 3 |
| Concentration | 1 mg/mL |
| Species reactivity | Human, Mouse, Rat |
| Observed band | 60 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Cancer, Cell Biology, Cardiovascular, Epigenetics and Nuclear Signaling, Metabolism, Microbiology, Neuroscience, Signal Transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human | |||||||
| Mouse | |||||||
| Rat |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.